A data information management method and system based on the field of medical research and development

Abstract

The present invention discloses a data information management method and system based on the field of pharmaceutical research and development, which relates to the field of pharmaceutical data management technology, including analyzing and processing access information, determining the location of a device that sends access information, and obtaining data authority information of the device; sending a pharmaceutical data service list to the location of the device that sends access information, and obtaining specific access information. The present invention first analyzes the location of the device that sends access information to determine the authority information of the device that sends access information, and then retrieves the specific access information of the visitor to determine whether the access data corresponding to the specific access information of the visitor is private data. If it is private data, the authority information of the device that sends the access information is analyzed to determine whether the authority information of the device that sends the access information can realize the reading or storage of pharmaceutical data, thereby realizing the management of pharmaceutical data, avoiding the leakage of pharmaceutical data, and reducing property losses.

Description

Technical Field

[0001] The present invention relates to the technical field of pharmaceutical data management, and in particular to a data information management method and system based on the pharmaceutical research and development field. Background Art

[0002] During the research and development process of pharmaceuticals, a variety of different clinical manifestations will occur, and these clinical manifestations are important references for the subsequent formal use. Therefore, these clinical manifestations need to be preserved. In order to avoid data leakage, these data must be managed confidentially to prevent them from being imitated by other companies and reduce property losses. Summary of the invention

[0003] In order to solve the above technical problems, a data information management method and system based on the field of pharmaceutical research and development is provided. This technical solution solves the problem of pharmaceutical research and development data being leaked and imitated by other companies, causing property losses, as mentioned in the above background technology.

[0004] In order to achieve the above purpose, the technical solution adopted by the present invention is:

[0005] A data information management method based on the field of pharmaceutical research and development, comprising:

[0006] Based on the core processor, the access information is analyzed and processed to determine the location of the device that sent the access information, and obtain the data permission information of the device; wherein the data permission information of the device is any one of no data access permission, partial data access permission and full data access permission;

[0007] Based on the core processor, a medical data service list is sent to the device location that sends the access information to obtain specific access information; wherein the specific access information is any one of the names of the read medical research and development data or the names of the stored medical research and development data;

[0008] Based on the core processor, the privacy of the specific access information is analyzed to determine the privacy of the specific access information;

[0009] The core processor sends the operation result to the device that sent the access information according to the privacy level of the specific access information.

[0010] Preferably, the core processor is used to analyze and process the access information, determine the location of the device that sends the access information, and obtain the data permission information of the device, specifically including the following steps:

[0011] Based on the core processor, the access information is parsed and processed to obtain the IP address of the access information;

[0012] Based on the core processor, the IP address of the access information is retrieved and processed to determine the device code that sent the access information;

[0013] The core processor performs information matching processing on the database system according to the device code sending the access information, and determines the location of the device sending the access information;

[0014] The core processor performs permission analysis based on the location of the device that sends the access information and determines the data permission information of the device.

[0015] Preferably, the core processor performs permission analysis according to the location of the device sending the access information, and determines the data permission information of the device, specifically including the following steps:

[0016] Based on the core processor, a data transmission instruction is sent to the database system to obtain a data permission distribution location; wherein the data permission distribution location includes a location without data permission access, a location with partial data permission access, and a location with full data permission access;

[0017] Based on the core processor, the device location that sends the access information and the data permission distribution location are matched;

[0018] If the location of the device sending the access information is at a location without data access permission, the data permission information of the output device is no data access permission;

[0019] If the location of the device sending the access information is located at a partial data access permission location, the data permission information of the output device is the partial data access permission;

[0020] If the device sending the access information is located at the full data access permission position, the data permission information of the output device is the full data access permission.

[0021] Preferably, the core processor is based on sending a medical data service list to the location of a device that sends access information, and obtaining specific access information specifically comprises the following steps:

[0022] The core processor generates a list of medical data services based on the location of the device sending the access information;

[0023] Based on the core processor, sending a list of medical data services to a location of a device accessing the information;

[0024] Visitors select a mode based on the medical data service list to obtain specific access information.

[0025] Preferably, the visitor selects a mode according to the medical data service list, and obtaining specific access information specifically includes the following steps:

[0026] The visitor selects service content according to the medical data service list; wherein the service content is specifically any one of a reading data service or a storing data service;

[0027] The visitor inputs the name of the access information to the device sending the access information, and the device sending the access information sends the name of the access information to the core processor;

[0028] The core processor searches the database system for data according to the name of the access information to obtain the name of the data related to the access information;

[0029] The core processor sends the data name related to the access information to the device that sends the access information, and the visitor selects the data name related to the access information to determine the specific access information.

[0030] Preferably, the core processor performs data retrieval from the database system according to the name of the access information, and obtains the name of the relevant data of the access information, specifically including the following steps:

[0031] The core processor retrieves data from the database system according to the name of the access information;

[0032] If there is medical data in the database system that matches the name of the access information, the core processor sends the name to the device that sent the access information;

[0033] If there is no medical data in the database system that is consistent with the name of the access information, the core processor segments the name of the access information to obtain the name keyword of the access information;

[0034] The core processor searches the database system for data according to the name keyword of the access information to obtain the relevant data name of the access information, and the core processor sends the relevant data name of the access information to the device sending the access information.

[0035] Preferably, the step of performing privacy analysis on the specific access information based on the core processor to determine the privacy of the specific access information specifically comprises the following steps:

[0036] The core processor searches the root directory of the database system for information based on the specific access information to obtain the permission information of the specific access information;

[0037] The core processor analyzes and processes the permission information of the specific access information to determine the privacy of the specific access information, where the privacy of the specific access information is either public or confidential.

[0038] Preferably, the core processor sends the operation result to the device sending the access information according to the privacy level of the specific access information, specifically comprising the following steps:

[0039] If the privacy of the specific access information is public;

[0040] Based on the core processor, a data operation process is sent to the device that sends the access information, and the visitor reads the medical data or stores the medical data according to the data operation process;

[0041] If the privacy of the specific access information is confidential;

[0042] The core processor chooses whether to send the data operation flow based on the location of the device sending the access information.

[0043] Preferably, the core processor selects whether to send data according to the location of the device sending the access information. The operation flow specifically includes the following steps:

[0044] If the location of the device sending the access information is a location without data access rights;

[0045] The core processor sends a data operation instruction to the authority manager corresponding to the specific access information, where the data operation instruction is specifically a data operation flow instruction;

[0046] If the location of the device sending the access information is a partial data access permission location;

[0047] The core processor determines the access rights to some data;

[0048] If the partial data access rights meet the privacy requirements of the specific access information, the core processor sends a data operation process to the device that sent the access information, and the visitor reads the medical data or stores the medical data according to the data operation process;

[0049] If some data access rights do not meet the privacy requirements of the specific access information, the core processor sends a data operation instruction to the authority manager corresponding to the specific access information;

[0050] If the location of the device sending the access information is the location of all data access permissions;

[0051] Based on the core processor, a data operation process is sent to the device that sends the access information, and the visitor reads or stores the medical data according to the data operation process.

[0052] Furthermore, a data information management system based on the field of pharmaceutical research and development is proposed, which is used to implement the data information management method based on the field of pharmaceutical research and development as described above, and is characterized by comprising:

[0053] A core processor, the core processor is used to analyze and process the access information, determine the location of the device that sent the access information, and obtain the data permission information of the device; the core processor is used to perform privacy analysis on the specific access information to determine whether medical data can be read or stored;

[0054] A database system, wherein the database system is used to store public medical data and confidential medical data;

[0055] A device for sending access information, wherein the device for sending access information is used to allow the visitor to store or read medical data;

[0056] The core processor internally integrates a main control unit, a data analysis unit, an instruction sending unit, a data retrieval unit, a medical data service list generating unit, a communication unit and a judgment unit.

[0057] Compared with the prior art, the present invention provides a data information management method and system based on the field of pharmaceutical research and development, which has the following beneficial effects:

[0058] The present invention first analyzes the location of the device sending the access information to determine the permission information of the device sending the access information, and then retrieves the specific access information of the visitor to determine whether the access data corresponding to the specific access information of the visitor is private data. If it is private data, the permission information of the device sending the access information is analyzed to determine whether the permission information of the device sending the access information can realize the reading or storage of pharmaceutical data, thereby realizing the management of pharmaceutical data, avoiding the leakage of pharmaceutical data, and reducing property losses. BRIEF DESCRIPTION OF THE DRAWINGS

[0059] Figure 1 This is a flow chart of steps S100-S400 in a data information management method based on the field of pharmaceutical research and development proposed by the present invention;

[0060] Figure 2 This is a flow chart of steps S101-S104 in a data information management method based on the field of pharmaceutical research and development proposed by the present invention;

[0061] Figure 3 This is a flow chart of steps S1041-S1045 in a data information management method based on the field of pharmaceutical research and development proposed by the present invention;

[0062] Figure 4 This is a flow chart of steps S201-S203 in a data information management method based on the field of pharmaceutical research and development proposed by the present invention;

[0063] Figure 5This is a flow chart of steps S2031-S2034 in a data information management method based on the field of pharmaceutical research and development proposed by the present invention;

[0064] Figure 6 This is a flow chart of steps S20331-S20334 in a data information management method based on the field of pharmaceutical research and development proposed by the present invention;

[0065] Figure 7 This is a flow chart of steps S301-S302 in a data information management method based on the field of pharmaceutical research and development proposed by the present invention;

[0066] Figure 8 This is a flow chart of steps S401-S404 in a data information management method based on the field of pharmaceutical research and development proposed by the present invention;

[0067] Fig. 9 This is a flow chart of steps S4041-S4048 in a data information management method based on the field of pharmaceutical research and development proposed by the present invention;

[0068] Fig.10 This is a structural block diagram of a data information management system based on the field of medical research and development proposed by the present invention. DETAILED DESCRIPTION

[0069] The following description is used to disclose the present invention so that those skilled in the art can implement the present invention. The preferred embodiments described below are only examples, and those skilled in the art may think of other obvious variations.

[0070] Reference Figure 1 As shown, a data information management method based on the field of pharmaceutical research and development includes:

[0071] S100, based on the core processor, analyzing and processing the access information, determining the location of the device that sent the access information, and obtaining the data permission information of the device; wherein the data permission information of the device is any one of no data access permission, partial data access permission, and full data access permission;

[0072] S200, based on the core processor, sending a medical data service list to the location of the device that sends the access information, and obtaining specific access information; wherein the specific access information is any one of the names of the read medical research and development data or the names of the stored medical research and development data;

[0073] S300, based on the core processor, performing privacy analysis on the specific access information to determine the privacy of the specific access information;

[0074] S400, the core processor sends the operation result to the device that sent the access information according to the privacy level of the specific access information;

[0075] It is understandable to those skilled in the art that during the research and development process of pharmaceuticals, there will be a variety of clinical manifestations, which provide an important reference for the subsequent normal use of the pharmaceuticals. However, other companies imitate the pharmaceuticals based on the data during the research and development process. Therefore, in order to prevent other companies from imitating the pharmaceuticals, the data during the research and development process of the pharmaceuticals must be kept confidential. When the pharmaceutical data needs to be read or stored, the visitor's access information needs to be analyzed to determine whether it involves confidential data. In pharmaceutical data management, certain devices will be granted permission to manage pharmaceutical data. Therefore, the management of pharmaceutical research and development data is achieved through a comprehensive analysis of the device's permissions and the visitor's access information.

[0076] Reference Figure 2 As shown, based on the core processor, the access information is analyzed and processed, the location of the device that sends the access information is determined, and the data permission information of the device is obtained, which specifically includes the following steps:

[0077] S101, based on the core processor, parsing the access information to obtain the IP address of the access information;

[0078] S102, based on the core processor, searching and processing the IP address of the access information to determine the device code that sends the access information;

[0079] S103, the core processor performs information matching processing on the database system according to the device code sending the access information, and determines the location of the device sending the access information;

[0080] S104, the core processor performs permission analysis according to the location of the device that sends the access information, and determines the data permission information of the device;

[0081] In this embodiment, some devices are granted the authority to manage pharmaceutical data. Therefore, by retrieving the IP address of the access information, the device code sending the access information is determined, and then based on the device code, it is determined whether the device sending the access information has the authority to manage data.

[0082] Reference Figure 3 As shown, the core processor performs permission analysis based on the location of the device that sends the access information, and determines the data permission information of the device, specifically including the following steps:

[0083] S1041. Based on the core processor, send a data transmission instruction to the database system to obtain a data permission distribution location; wherein the data permission distribution location includes a location with no data permission access, a location with partial data permission access, and a location with full data permission access;

[0084] S1042, based on the core processor, matching the location of the device sending the access information and the data permission distribution location;

[0085] S1043: If the location of the device sending the access information is at a location without data access permission, the data permission information of the output device is that there is no data access permission;

[0086] S1044: If the location of the device sending the access information is located at a partial data access permission location, the data permission information of the output device is the partial data access permission;

[0087] S1045: If the location of the device sending the access information is at the location of all data access rights, the data permission information of the output device is all data access rights;

[0088] In this embodiment, devices in public areas generally do not have the authority to manage data, while some R&D personnel's devices are located in confidential areas. However, not all R&D personnel's devices have the authority to manage all data. They may only have the authority to manage some data. Some specific managers have the authority to manage all pharmaceutical data, but their devices are placed in fixed areas. Therefore, by analyzing the data permission distribution location, it is determined whether the device sending the access information has the authority to manage the data.

[0089] Reference Figure 4 As shown, based on the core processor, a medical data service list is sent to the device location that sends the access information, and obtaining specific access information specifically includes the following steps:

[0090] S201, the core processor generates a medical data service list according to the location of the device sending the access information;

[0091] S202, based on the core processor, sending a medical data service list to a device location that accesses information;

[0092] S203: The visitor selects a mode according to the medical data service list to obtain specific access information.

[0093] Reference Figure 5 As shown, the visitor selects a mode based on the medical data service list, and obtaining specific access information includes the following steps:

[0094] S2031, the visitor selects service content according to the medical data service list; wherein the service content is specifically any one of a reading data service or a storing data service;

[0095] S2032, the visitor inputs the name of the access information to the device sending the access information, and the device sending the access information sends the name of the access information to the core processor;

[0096] S2033, the core processor searches the database system for data according to the name of the access information, and obtains the name of the data related to the access information;

[0097] S2034. The core processor sends the data name related to the access information to the device that sends the access information. The visitor selects the data name related to the access information to determine the specific access information.

[0098] Reference Figure 6 As shown, the core processor searches the database system for data according to the name of the access information, and obtains the name of the data related to the access information, specifically including the following steps:

[0099] S20331, the core processor retrieves data from the database system according to the name of the access information;

[0100] S20332. If there is medical data in the database system that has the same name as the access information, the core processor sends the name to the device that sent the access information;

[0101] S20333. If the database system does not contain medical data that is consistent with the name of the access information, the core processor segments the name of the access information to obtain a keyword for the name of the access information;

[0102] S20334, the core processor performs data retrieval on the database system according to the name keyword of the access information, obtains the name of the data related to the access information, and sends the name of the data related to the access information to the device sending the access information;

[0103] In this embodiment, when a visitor enters the name of the data to be accessed, he may enter the wrong keyword, resulting in the inability to retrieve the corresponding pharmaceutical data. Therefore, by segmenting the name of the access information and performing a keyword search, multiple groups of related data are retrieved through the keyword for the visitor to choose from, so that the visitor can select the required data.

[0104] Reference Figure 7 As shown, based on the core processor, the privacy analysis of the specific access information is performed to determine the privacy of the specific access information, which specifically includes the following steps:

[0105] S301, the core processor searches the root directory of the database system for information according to the specific access information to obtain the permission information of the specific access information;

[0106] S302: The core processor analyzes and processes the permission information of the specific access information to determine the privacy level of the specific access information, where the privacy level of the specific access information is either public or confidential.

[0107] Reference Figure 8 As shown, the core processor sends the operation result to the device sending the access information according to the privacy of the specific access information, which specifically includes the following steps:

[0108] S401, if the privacy of the specific access information is public;

[0109] S402, based on the core processor, sending a data operation process to the device that sends the access information, and the visitor reads the medical data or stores the medical data according to the data operation process;

[0110] S403, if the privacy of the specific access information is confidential;

[0111] S404: The core processor selects whether to send the data operation process according to the location of the device sending the access information.

[0112] Reference Fig. 9 As shown, the core processor selects whether to send data according to the location of the device sending the access information. The operation flow specifically includes the following steps:

[0113] S4041, if the location of the device sending the access information is a location without data access rights;

[0114] S4042, the core processor sends a data operation instruction to the authority manager corresponding to the specific access information, wherein the data operation instruction is specifically a data operation flow instruction;

[0115] S4043, if the location of the device sending the access information is a location of partial data access rights;

[0116] S4044, the core processor determines access rights to some data;

[0117] S4045. If the partial data access rights meet the privacy requirements of the specific access information, the core processor sends a data operation process to the device that sends the access information, and the visitor reads the medical data or stores the medical data according to the data operation process;

[0118] S4046. If the partial data access rights do not satisfy the privacy of the specific access information, the core processor sends a data operation instruction to the authority manager corresponding to the specific access information;

[0119] S4047, if the location of the device sending the access information is the location of all data access rights;

[0120] S4048, based on the core processor, sending a data operation process to the device that sent the access information, and the visitor reads the medical data or stores the medical data according to the data operation process;

[0121] In this embodiment, when the privacy of specific access information is confidential, it is necessary to analyze the permissions of the device sending the access information to determine whether it can perform data management. If the permissions of the device sending the access information can achieve pharmaceutical data management, the visitor can directly store or read the pharmaceutical data. If the permissions of the device sending the access information do not meet the privacy of the pharmaceutical data, the visitor needs to apply to the pharmaceutical data manager for permission to read or store the data, thereby achieving strict management of pharmaceutical data, avoiding the leakage of pharmaceutical data, and reducing property losses.

[0122] Reference Fig.10 As shown, a data information management system based on the field of pharmaceutical research and development is used to implement the data information management method based on the field of pharmaceutical research and development as described above, characterized in that it includes:

[0123] A core processor, the core processor is used to analyze and process the access information, determine the location of the device that sent the access information, and obtain the data permission information of the device; the core processor is used to perform privacy analysis on the specific access information to determine whether medical data can be read or stored;

[0124] A database system, wherein the database system is used to store public medical data and confidential medical data;

[0125] A device for sending access information, wherein the device for sending access information is used to allow the visitor to store or read medical data;

[0126] The core processor internally integrates a main control unit, a data analysis unit, an instruction sending unit, a data retrieval unit, a medical data service list generating unit, a communication unit and a judgment unit.

[0127] The above shows and describes the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited to the above embodiments. The above embodiments and descriptions only describe the principles of the present invention. The present invention may be subject to various changes and improvements without departing from the spirit and scope of the present invention. These changes and improvements fall within the scope of the present invention. The scope of protection claimed by the present invention is defined by the attached claims and their equivalents.

Claims

1. A data information management method based on the field of pharmaceutical research and development, characterized in that: include: Based on the core processor, the access information is analyzed and processed to determine the location of the device that sent the access information, and obtain the data permission information of the device; wherein the data permission information of the device is any one of no data access permission, partial data access permission and full data access permission; Based on the core processor, a medical data service list is sent to the device location that sends the access information to obtain specific access information; wherein the specific access information is any one of the names of the read medical research and development data or the names of the stored medical research and development data; Based on the core processor, the privacy of the specific access information is analyzed to determine the privacy of the specific access information; The core processor sends the operation result to the device that sent the access information according to the privacy level of the specific access information.

2. A data information management method based on the field of pharmaceutical research and development according to claim 1, characterized in that: The core processor is used to analyze and process the access information, determine the location of the device that sent the access information, and obtain the data permission information of the device, which specifically includes the following steps: Based on the core processor, the access information is parsed and processed to obtain the IP address of the access information; Based on the core processor, the IP address of the access information is retrieved and processed to determine the device code that sends the access information; The core processor performs information matching processing on the database system according to the device code sending the access information, and determines the location of the device sending the access information; The core processor performs permission analysis based on the location of the device that sends the access information and determines the data permission information of the device.

3. A data information management method based on the field of pharmaceutical research and development according to claim 2, characterized in that: The core processor performs permission analysis according to the location of the device sending the access information, and determines the data permission information of the device, specifically including the following steps: Based on the core processor, a data transmission instruction is sent to the database system to obtain a data permission distribution location; wherein the data permission distribution location includes a location without data permission access, a location with partial data permission access, and a location with full data permission access; Based on the core processor, the device location that sends the access information and the data permission distribution location are matched; If the location of the device sending the access information is at a location without data access permission, the data permission information of the output device is no data access permission; If the location of the device sending the access information is located at a partial data access permission location, the data permission information of the output device is the partial data access permission; If the device sending the access information is located at the full data access permission position, the data permission information of the output device is the full data access permission.

4. A data information management method based on the field of pharmaceutical research and development according to claim 1, characterized in that: The core processor sends a medical data service list to the device location that sends the access information, and obtains the specific access information, specifically including the following steps: The core processor generates a list of medical data services based on the location of the device sending the access information; Based on the core processor, sending a list of medical data services to a location of a device accessing the information; Visitors select a mode based on the medical data service list to obtain specific access information.

5. A data information management method based on the field of pharmaceutical research and development according to claim 4, characterized in that: The visitor selects a mode according to the medical data service list, and obtaining specific access information specifically includes the following steps: The visitor selects service content according to the medical data service list; wherein the service content is specifically any one of a reading data service or a storing data service; The visitor inputs the name of the access information to the device sending the access information, and the device sending the access information sends the name of the access information to the core processor; The core processor searches the database system for data according to the name of the access information to obtain the name of the data related to the access information; The core processor sends the data name related to the access information to the device that sends the access information, and the visitor selects the data name related to the access information to determine the specific access information.

6. A data information management method based on the field of pharmaceutical research and development according to claim 5, characterized in that: The core processor searches the database system for data according to the name of the access information, and obtains the name of the data related to the access information, specifically including the following steps: The core processor retrieves data from the database system according to the name of the access information; If there is medical data in the database system that matches the name of the access information, the core processor sends the name to the device that sent the access information; If there is no medical data in the database system that is consistent with the name of the access information, the core processor segments the name of the access information to obtain the name keyword of the access information; The core processor searches the database system for data according to the name keyword of the access information to obtain the relevant data name of the access information, and the core processor sends the relevant data name of the access information to the device sending the access information.

7. A data information management method based on the field of pharmaceutical research and development according to claim 1, characterized in that: The step of performing privacy analysis on the specific access information based on the core processor to determine the privacy of the specific access information specifically includes the following steps: The core processor searches the root directory of the database system for information based on the specific access information to obtain the permission information of the specific access information; The core processor analyzes and processes the permission information of the specific access information to determine the privacy of the specific access information, where the privacy of the specific access information is either public or confidential.

8. A data information management method based on the field of pharmaceutical research and development according to claim 1, characterized in that: The core processor sends the operation result to the device sending the access information according to the privacy degree of the specific access information, specifically including the following steps: If the privacy of the specific access information is public; Based on the core processor, a data operation process is sent to the device that sends the access information, and the visitor reads the medical data or stores the medical data according to the data operation process; If the privacy of the specific access information is confidential; The core processor chooses whether to send the data operation flow based on the location of the device sending the access information.

9. A data information management method based on the field of pharmaceutical research and development according to claim 8, characterized in that: The core processor selects whether to send data according to the location of the device sending the access information. The operation flow specifically includes the following steps: If the location of the device sending the access information is a location without data access rights; The core processor sends a data operation instruction to the authority manager corresponding to the specific access information, wherein the data operation instruction is specifically a data operation flow instruction; If the location of the device sending the access information is a partial data access permission location; The core processor determines the access rights to some data; If the partial data access rights meet the privacy requirements of the specific access information, the core processor sends a data operation process to the device that sent the access information, and the visitor reads the medical data or stores the medical data according to the data operation process; If some data access rights do not meet the privacy requirements of the specific access information, the core processor sends a data operation instruction to the authority manager corresponding to the specific access information; If the location of the device sending the access information is the location of all data access permissions; Based on the core processor, a data operation process is sent to the device that sends the access information, and the visitor reads or stores the medical data according to the data operation process.

10. A data information management system based on the field of pharmaceutical research and development, used to implement a data information management method based on the field of pharmaceutical research and development as claimed in any one of claims 1 to 9, characterized in that: include: A core processor, the core processor is used to analyze and process the access information, determine the location of the device that sent the access information, and obtain data permission information of the device; The core processor is used to perform privacy analysis on specific access information to determine whether medical data reading or medical data storage can be performed; A database system, wherein the database system is used to store public medical data and confidential medical data; A device for sending access information, wherein the device for sending access information is used to allow the visitor to store or read medical data; The core processor internally integrates a main control unit, a data analysis unit, an instruction sending unit, a data retrieval unit, a medical data service list generating unit, a communication unit and a judgment unit.

Images